CT-2584
CT-2584 is an anticancer agent that inhibits phospholipid signaling and kills tumor cells through the production of reactive oxygen intermediates. CT-2584 reduces NKEF-B expression in several tumor cell types. CT-2584 reduced tumor growth in SCID mice by causing shunting of ab initio phospholipid biosynthesis from phosphatidylcholine (PC) to phosphatidylinositol (PI) via PA.
Product Specifications
CAS Number
166981-13-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
533.79
Molecular Formula
C30H55N5O3
Notes
Research use only, not for human use.
Receptor
Reactive Oxygen Species
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL315268V 500 µL Each
C12orf69 (SMCO3) Human shRNA Lentiviral Particle (Locus ID 440087)
Ask
View Details 
MBS6193309-01 0.1 mL
UCHL1 (Ubiquitin Carboxyl-terminal Hydrolase Isozyme L1, UCH-L1, Neuron Cytoplasmic Protein 9.5, PGP 9.5, PGP9.5, Ubiquitin Thioesterase L1) (MaxLight 405)
Ask
View Details MBS6193309-02 5x 0.1 mL
UCHL1 (Ubiquitin Carboxyl-terminal Hydrolase Isozyme L1, UCH-L1, Neuron Cytoplasmic Protein 9.5, PGP 9.5, PGP9.5, Ubiquitin Thioesterase L1) (MaxLight 405)
Ask
View Details